Early research (Phase 1)Study completedNCT01632332
What this trial is testing
Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer
Who this might be right for
HER2-positive Breast CancerMale Breast CancerStage II Breast Cancer+3 more
Mayo Clinic 22